Elahere 72903-0853
Generic: Mirvetuximab Soravtansine
Product NDC
72903-0853- Manufacturer
- Immunogen, Inc.
- Dosage Form
- Injection, Solution
- Route
- Intravenous
- Product Type
- Human Prescription Drug
- Marketing Start
- November 14, 2022
- Listing Expires
- December 31, 2027
- Application
- BLA761310
Need to source Elahere? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Mirvetuximab Soravtansine | 5 mg/mL |
Packaging Options(1)
1 VIAL, SINGLE-USE in 1 CARTON (72903-853-01) / 20 mL in 1 VIAL, SINGLE-USE